Literature DB >> 7958678

Crohn's disease and cancer: a population-based cohort study.

P G Persson1, P Karlén, O Bernell, C E Leijonmarck, O Broström, A Ahlbom, G Hellers.   

Abstract

BACKGROUND/AIMS: To study the association between Crohn's disease and cancer, we performed a population-based study of 1251 subjects with Crohn's disease diagnosed in Stockholm from 1955 to 1984 and followed in both the National Cancer Register and the National Cause-of-Death Register until 1989.
METHODS: For comparisons, regional cancer incidence rates in Stockholm County were used together with individually computed person-years at risk in the Crohn's disease cohort.
RESULTS: Overall, 69 malignancies occurred among 67 individuals as compared with 59.80 expected malignancies (standardized morbidity ratio [SMR] = 1.15; 95% confidence interval, 0.90-1.46). An excess number of cancers of the upper gastrointestinal tract (SMR, 3.05; 95% confidence interval, 1.67-5.11) was observed, mainly because of an increased number of cancers of the small intestine (SMR, 15.64; 95% confidence interval, 4.26-40.06). An increased occurrence of urinary bladder cancer was also observed (SMR, 2.68; 95% confidence interval, 1.08-5.53).
CONCLUSIONS: The occurrence of colorectal cancer was not increased.

Entities:  

Mesh:

Year:  1994        PMID: 7958678     DOI: 10.1016/0016-5085(94)90807-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  52 in total

1.  Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.

Authors:  R J Farrell; Y Ang; P Kileen; D S O'Briain; D Kelleher; P W Keeling; D G Weir
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease.

Authors:  W J Sandborn; E V Loftus
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Current trends in inflammatory bowel disease: the natural history.

Authors:  Ebbe Langholz
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

4.  p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease.

Authors:  Jeffrey W Nathanson; Nicole E Yadron; Jeanne Farnan; Sydney Kinnear; John Hart; David T Rubin
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

5.  Clinical epidemiology--how important now?

Authors:  V Binder
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

6.  Distal adenomatous polyps are rare in patients with inflammatory bowel disease.

Authors:  A Dixon; P Wurm; A Hart; R Robinson
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

7.  Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients.

Authors:  Stefano Scaringi; Carmela Di Martino; Daniela Zambonin; Marilena Fazi; Giuseppe Canonico; Francesca Leo; Ferdinando Ficari; Francesco Tonelli
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

Review 8.  Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.

Authors:  Elyse A Linson; Stephen B Hanauer
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02

9.  Colonic Crohn's disease.

Authors:  Steven Mills; Michael J Stamos
Journal:  Clin Colon Rectal Surg       Date:  2007-11

Review 10.  Cancer in inflammatory bowel disease.

Authors:  Jianlin Xie; Steven H Itzkowitz
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.